ALPN Research and Charts

ALPN - Alpine Immune Sciences Inc (Healthcare: Biotechnology)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2024-09-09)

Last 64.97	Change ⇓ 0.00 (0.00%)	Volume 2
	Open 64.97	High 64.97	Low 64.97

8EMA (Daily) 64.96	40EMA (Daily) 59.75	50EMA (Daily) 57.27	STO (Daily) 87.560	MACD Hist (Daily) -1.250
8EMA (Weekly) 63.793	40EMA (Weekly) 42.63	50EMA (Weekly) 38.43	STO (Weekly) 99.902	MACD Hist (Weekly) -0.953


Company Profile
Alpine Immune Sciences Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing innovative, protein-based immunotherapies to treat cancer and autoimmune and inflammatory diseases. The company's proprietary scientific platform uses a process known as directed evolution to create therapeutics capable of modulating human immune system proteins. Its product pipeline includes ALPN-101 and ALPN-202.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.